Back to results
US 12,213,989 B2Granted
Use of maribavir in treatment regimens
AssigneeTakeda Pharmaceutical Company Limited
InventorsHeng Song, Kefeng Sun, Matthew Crouthamel, Grace Chen, Andy Z. X. Zhu, Ingrid Nicolle Michon, Howard James Burt, Zoe Elizabeth Barter, Sibylle Neuhoff
Life of this patent
Estimating the term…
Abstract
Characterization of drug-drug interaction properties and pharmacological properties of maribavir is useful to inform potential drug-drug interactions and dosing strategies when administering with co-medications.
Claims7
A method of treating cytomegalovirus (CMV) infection in a patient suffering therefrom, the method comprising
- administering maribavir in an amount of 1200 mg orally twice daily, wherein the patient is a transplant recipient concomitantly exposed to or receiving an anticonvulsant selected from phenytoin or phenobarbital,
- wherein maribavir is administered prior to, concurrently with, or subsequently from the administration of the anticonvulsant.
Dependencies are inferred from the claim text.